MEDICINA
Departamento
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (9)
2022
-
Beta-3 adrenergic receptor overexpression reverses aortic stenosis–induced heart failure and restores balanced mitochondrial dynamics
Basic Research in Cardiology, Vol. 117, Núm. 1
2020
-
A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart
Cell, Vol. 183, Núm. 1, pp. 94-109.e23
-
The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis
Scientific Reports, Vol. 10, Núm. 1
2018
-
Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction
Journal of Cardiovascular Translational Research, Vol. 11, Núm. 4, pp. 310-318
-
Spanish National Hip Fracture Registry (SNHFR): a description of its objectives, methodology and implementation
Revista Espanola de Geriatria y Gerontologia, Vol. 53, Núm. 4, pp. 188-195
2016
-
Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort JC virus seroprevalence in Spain
Journal of the Neurological Sciences, Vol. 365, pp. 16-21
-
Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension
Basic Research in Cardiology, Vol. 111, Núm. 4
2008
-
Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness
Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1234-1240
2003
-
Effect of AT
1
receptor blockade on hepatic redox status in SHR: Possible relevance for endothelial function?
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 285, Núm. 3 54-3